Rapport Therapeutics, Inc. Common Stock

RAPP· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$40.79-0.46%

2026-08-03

Financials

Valuation Metrics

Rapport Therapeutics, Inc. Common Stock's Market Cap is $1.95B. At end of 2025 it was $1.43B. Ranked #2071 of 3,112 in US market (top 67%), #798 of 1,445 on NASDAQ (top 55%), #138 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 51%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$1.95B	US#2,071/3,112 Sec#138/269
Revenue	$20M	US#2,904/3,112 Sec#173/269
Net Income	$-107M	US—/3,112 Sec—/269
Total Assets	$498M	US#2,747/3,112 Sec#159/269
Net Assets	$472M	US#2,295/3,112 Sec#118/269
Value
P/B	4.14x	US#2,002/3,112 Sec#120/269
P/S	97.54x	US#2,908/3,112 Sec#180/269
FCF Yield	-4.14%	US—/3,112 Sec—/269
Profitability
ROE	-22.75%	US#2,555/3,112 Sec#108/269
ROA	-21.56%	US#2,795/3,112 Sec#131/269
Op. Margin	-611.03%	US#2,904/3,112 Sec#168/269
Financial Health
Debt Ratio	5.53%	US#54/3,112 Sec#23/269
Total Debt	$11M	US#2,778/3,112 Sec#196/269
FCF	$-81M	US#2,547/3,112 Sec#137/269
Cash	$78M	US#2,353/3,112 Sec#192/269
Current Ratio	27.08x	US#94/3,112 Sec#15/269
Performance
1Y Return	188.27%	US#111/3,112 Sec#38/269
1M Return	4.67%	US#992/3,112 Sec#41/269
From 52W High	-7.88%	US#852/3,112 Sec#39/269
1Y MDD	-28.82%	US#1,292/3,112 Sec#81/269
Trading
Volume	310,264 shares	US#2,398/3,112 Sec#234/269
Trading Value	$13M	US#2,233/3,112 Sec#177/269
Per Share
EPS	$-2.37	US—/3,112 Sec—/269
BPS	$10.32	US#1,758/3,112 Sec#61/269